prediabetes and glp 1 GLP-1 Medications – Community Education Comparing Glucagon‐like peptide‐1 receptor agonists

A large retrospective cohort study published in early 2026 (Barnett et al., Cureus) matched nearly 390,000 diabetic patients on GLP-1 therapy against a similar number not on GLP-1 therapy 4

Results The p53 TAD2 region plays a crucial role in the interaction with FOXO4 FHD Interactions between FOXO4 and p53 in the nucleus have been reported to promote cellular senescence 34

Because these medications reduce appetite and slow stomach emptying, people may eat less and feel full longer, which can lead to lower fluid intake if hydration isnt intentional

This applies to CJC-1295, Ipamorelin, and all other secretagogues